HealthFDA warns GLP-1 drugs may raise risk of rare vision-loss condition
The FDA says popular GLP-1 drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, may increase the risk of a rare eye condition that can cause permanent vision loss. It will require manufacturers to add a warning to drug labels, though whether the medicines are linked to the condition remains uncertain.
FDA warns GLP-1 drugs may raise risk of rare vision-loss condition
Health